AdAlta $0.024
(0.00%)
|
High $0.03 |
Low $0.02 |
Trades 24 |
Turnover $54,432 |
Volume 2,170,184 |
| 30 June 2023 at 3:59pm | ||||
ADALTA LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $8,030,422 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
Company Presentation - AusBiotech and Bio-Europe
1AD released this announcement to the ASX on 22 October 2021, 12:32. The announcement is not marked as price sensitive, and is 28 page(s) in length and 6.91MB in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Company Presentation - AusBiotech and Bio-Europe | 22 October 2021, 12:32 |
| Quarterly Appendix 4C and Activities Report | 14 October 2021, 8:24 |
| BTB funding transferred to AD-214 inhalation program | 7 October 2021, 8:23 |
| Notification of Date of 2021 AGM | 4 October 2021, 8:52 |
If you were already registered, log in here.
If you were already registered, log in here.